IZI. A. Zolotovskaya

I. A. Zolotovskaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. A. Zolotovskaya has a total of 178 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chronic kidney disease and coronary artery disease: risk stratification

    by I. A. Zolotovskaya, M. E. Ramodina, A. I. Sizova, M. A. Pashina, P. R. Shatskaya, И. А. Золотовская, М. Е. Рамодина, А. И. Сизова, М. А. Пашина, П. Р. Шацкая

    Currently, the search for reliable biomarkers that combine high sensitivity and specificity and allow for the accurate diagnosis of chronic kidney disease (CKD) in patients with coronary artery disease (CAD) remains a key challenge in modern medicine. This study presents a systematic review of the current literature on the relationship between CKD and CAD, with a focus on risk stratification and the diagnostic value of specific biomarkers. The search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and included the following databases: PubMed, Scopus, Web of Science, Google Scholar, CyberLeninka, eLibrary, and Clinical Trials. The quality of the selected publications was assessed using the Newcastle-Ottawa Scale for cohort studies and AMSTAR 2 for systematic reviews and meta-analyses. This literature review allowed us to systematize current data on the relationship between CKD and CAD and evaluate the role of key biomarkers in risk stratification in this patient population. The combination of these conditions creates a unique pathophysiological profile that requires special attention in both diagnosis and treatment. Biomarkers that require emphasis for more accurate risk stratification are described. This review demonstrated that CKD is an independent and powerful predictor of adverse outcomes after MI, stenting, and coronary artery bypass grafting. It is shown that therapy in this patient population requires an individualized approach.

  • Open Access

    Gender and age effects on coronary calcium index in patients with suspected CHD

    by P. R. Shatskaya, Olesya A. Rubanenko, Irina Zolotovskaya, Elena V. Adonina, Dmitry V. Duplyakov, Шацкая Полина Романовна, Karina Kuznetsova, Кузнецова Карина Владиславовна, Ekaterina Sukhinina, Сухинина Екатерина Михайловна, et al.

    Aim – to assess the influence of sex and age on the coronary artery calcium (CAC) score in patients with suspected coronary heart disease (CHD). Material and methods. A prospective, observational, single-center study was conducted. The study included 733 patients (mean age 67 [58; 73] years, 43.37% male) with suspected CHD who underwent multi-slice computed tomography (MSCT) of the coronary arteries with CAC scoring (using the Agatston method), as well as a biochemical blood test assessing lipid profile, glucose level, creatinine level, and estimated glomerular filtration rate (eGFR). An analysis of baseline clinical and laboratory parameters and the distribution of CAC scores according to patient age and sex was performed. Statistical analysis was performed using SPSS Statistics 21.0, employing the Shapiro-Wilk test, Student’s t-test, and ANOVA. Results. It was found that CAC scores increased with advancing age, and men had significantly higher CAC scores than women of the same age category. In the group of patients with higher CAC scores, older men were more prevalent, and there were higher creatinine levels and a higher incidence of atrial fibrillation. The correlation analysis revealed moderate and strong associations between CAC scores and parameters of lipid metabolism, as well as eGFR. Conclusion. The assessment of CAC scores, taking into account sex and age, improves the accuracy of cardiovascular risk stratification in patients with suspected CHD. The implementation of this approach into clinical practice helps optimize preventive and therapeutic strategies for reducing cardiovascular morbidity and mortality.

  • Open Access

    Impact of vaccination status on the clinical course and outcomes of acute COVID-19 period: data from the international registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV-4)

    by G Arutyunov, E Tarlovskaya, A Arutyunov, D Polyakov, Yu. Lopatin, A Chesnikova, L Balykova, A Vaisberg, A Galyavich, N Grigorieva, et al.

    Aim. To assess the effectiveness of vaccination against Omicron and Delta variants according to the international registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV-4).Material and methods. The AKTIV-4 registry included men and women over 18 years of age with a diagnosis of coronavirus disease 2019 (COVID-19) (oropharyngeal and nasopharyngeal swabs, SARS-CoV-2 antibody titers, typical computed tomography performance), undergoing hospital treatment. A total of 3543 patients from 25 medical centers in 7 countries (the Russian Federation, the Republic of Armenia, the Republic of Belarus, the Republic of Kazakhstan, the Kyrgyz Republic, the Republic of Moldova, and the Republic of Uzbekistan) were included in the AKTIV-4 registry.Results. The clinical status of patients from the AKTIV-4 registry was more severe than in the AKTIV-1 and AKTIV-2 registries. Patients in the AKTIV-4 registry were older than patients in the AKTIV-1 registry. The inhospital mortality rate in patients in the AKTIV-4 registry was higher (8,41%, pConclusion. Vaccination, primarily with Sputnik V, is an independent predictor of survival in hospitalized COVID-19 patients and reduces the risk of death by 62% according to multivariate analysis.

  • Open Access

    Gender cardiology: clinical and pathophysiological features of the course the main diseases in women

    by I. L. Davydkin, В. П. Кузьмин, I. A. Zolotovskaya, R. K. Hayretdinov, S. P. Krivova, O. A. Rubanenko

    Coronary heart disease is the leading cause of death for both women and men. Older women, when coronary heart disease first appears, have more comorbidities and usually complain of atypical symptoms. Mortality and hospitalization rates caused by acute myocardial infarction are higher for women. It should be noted that adherence to secondary prevention for women is lower.Female predominance has been noted in idiopathic pulmonary arterial hypertension (IPAH), hereditary pulmonary hypertension, and collagenosisassociated pulmonary arterial hypertension. However, according to the latest data of the European register COMPERA, gender differences disappear for elderly patients and for the patients having concomitant diseases. The more frequent occurrence of cardiomyopathies among women is considered. Peripartum cardiomyopathy associated with pregnancy and childbirth, and Takotsubo cardiomyopathy due to psychoemotional status, in particular a stressful situation, determines a woman's further prognosis. Arrythmias are explained by changes in hormonal status during pregnancy, menopause, or are associated with the onset of the underlying disease.Heart failure usually affects both sexes equally, with women more likely to suffer from HFpEF and men from HFrEF. The classic cardiovascular, gender, and social risk factors for cardiovascular disease and heart failure have a different meaning for women than for men. It is necessary to take into account the parameters for EchoCG diagnostics for women, since the size of the women heart is smaller.